American College of Cardiology

American College of Cardiology The American College of Cardiology (ACC) is a global leader dedicated to transforming cardiovascular care and improving heart health for all.

08/28/2026

What stood out on Day 1 of 2026?

ACC Clinical Content Editor-in-Chief Fred M. Kusumoto and ACC Assembly of International Governors Chair-Elect Xavier Escudero, MD, FACC, share their early observations from Munich, including the science generating the most discussion, emerging trends in cardiovascular care.

Follow along as we bring you key insights and coverage from : https://bit.ly/4gysXzv

📣 Get Ready With the 🆕 Practice AssessmentDesigned to familiarize you with the format, structure, timing and question ...
08/28/2026

📣 Get Ready With the 🆕 Practice Assessment

Designed to familiarize you with the format, structure, timing and question style of the CCK Exam, it offers 3️⃣ practice attempts and detailed score reports to help you build familiarity, confidence and readiness.

Explore now ↪️ https://bit.ly/4cRbSj0

Despite premature termination limiting the precision of mortality estimates, the REBOOT-PARADOX trial offers rare random...
08/28/2026

Despite premature termination limiting the precision of mortality estimates, the REBOOT-PARADOX trial offers rare randomized, long-term patient-level data examining vs. OMT in symptomatic patients with paradoxical low-flow, low-gradient aortic stenosis.

Read more: https://bit.ly/4gBBIZk

08/28/2026

ACC Anywhere TV Live from Munich! 📺

ACC Immediate Past President Dr. Christopher Kramer discusses some of the trials presented during Hot Line 1 at 2026. In particular, Kramer was excited by the results of ACACIA-HCM, CMR Guide & CARDIO-TTransform.

Find more coverage at: https://bit.ly/4gAFan1

Vericiguat did not improve peripheral vasodilator function or anginal symptoms in ANOCA patients with coronary vasospasm...
08/28/2026

Vericiguat did not improve peripheral vasodilator function or anginal symptoms in ANOCA patients with coronary vasospasm, based on findings from the ViVA trial presented at . However, researchers said the treatment was generally tolerated. Read more: https://bit.ly/3UnUwnJ

Findings from CMR Guide show ICD implantation did not reduce sudden cardiac death or hemodynamically significant ventric...
08/28/2026

Findings from CMR Guide show ICD implantation did not reduce sudden cardiac death or hemodynamically significant ventricular arrhythmia compared with an implantable loop recorder in patients with an LVEF of 36%-50% and myocardial scar.

🔎 Get the details and follow ACC's meeting coverage from : https://bit.ly/3SDJNF8

Patients with symptomatic nonobstructive HCM who were treated with aficamten vs. placebo saw significantly greater impro...
08/28/2026

Patients with symptomatic nonobstructive HCM who were treated with aficamten vs. placebo saw significantly greater improvement in symptom burden and exercise capacity at 36 weeks, according to findings from the ACACIA-HCM trial at .

Read more from ACC's coverage in Munich: https://bit.ly/4gjLhgQ

08/28/2026

🎊 We're celebrating a major milestone!

Join the ACC and Sociedad Colombiana de Cardiología y Cirugía Cardiovascular for 2026! This milestone event marks 🔟 years of ACC's International Conferences in Latin America, celebrating a decade of collaboration, innovation and impact. 🎉

Don’t miss these plenary sessions:
☑️ in Cardiology: What’s Real, What’s Ready, and What’s Next
☑️ An Integrated Challenge in Subclinical Primary Prevention: Heart (The Young) and Brain (The Elderly)
☑️ What’s New in Cardiovascular Guidelines: Implications for Practice
☑️ Top Clinical Trials to Impact Your Practice

📍 Medellín, Colombia
📅 17-19 September

📖 Learn more and register now ➡️ https://bit.ly/4cN0zcC

The Fifth Universal Definition of Myocardial Infarction released on behalf of a joint task force from the ACC, ESC, AHA ...
08/28/2026

The Fifth Universal Definition of Myocardial Infarction released on behalf of a joint task force from the ACC, ESC, AHA and WHF provides a 🆕 clinical classification of that is based on pathophysiology, aligns with clinical evaluation of patients and incorporates objective diagnostic criteria.

Read the highlights from the updated definition 👉 https://bit.ly/4y53W63

A POET-II HaikuTailored care responds,Two weeks less antibiotics,Relapse risk may rise.Read all about it in ACC's covera...
08/28/2026

A POET-II Haiku

Tailored care responds,
Two weeks less antibiotics,
Relapse risk may rise.

Read all about it in ACC's coverage of : https://bit.ly/3UpmpvB

Address

2400 N St NW
Washington D.C., DC
20037

Website

Alerts

Be the first to know and let us send you an email when American College of Cardiology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Featured

Share

Category